What is Xencor Inc (XNCR) stock price today?

Xencor Inc (XNCR) currently trades at $11.93 per share. The stock has a market capitalization of $861.36M and a P/E ratio of —x.

Is XNCR stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Xencor Inc has a Smart Value Score of 28/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Xencor Inc's revenue and earnings?

Xencor Inc has trailing twelve-month (TTM) revenue of $125.58M with profit margins of -73.20%. Earnings per share (EPS) is $-1.24.

Is XNCR stock overvalued or undervalued?

Based on our DCF model, Xencor Inc's intrinsic value is $41.34, representing a margin of safety of 70.44%. The stock currently trades at a P/E of —x.

XNCR

Xencor Inc

NASDAQ: XNCR · HEALTHCARE · BIOTECHNOLOGY

$11.93

+2.67% today

Updated 2026-04-30

Market cap

$861.36M

P/E ratio

—

P/S ratio

6.86x

EPS (TTM)

$-1.24

Dividend yield

—

52W range

$7 – $19

Volume

0.9M

Market cap

$861.36M

P/E ratio

—

P/S ratio

6.86x

EPS (TTM)

$-1.24

Dividend yield

—

52W range

$7 – $19

Volume

0.9M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$28.42

+138.22%

12-Month target

—

Intrinsic (DCF)

$41.34

Margin of safety

+70.44%

3 Strong Buy9 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ 70.44% below intrinsic value

Risks

- Thin margins at -73.20%

- Negative free cash flow $-52.85M

- Revenue declining -46.50% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$164.58M	$168.34M	$110.49M	$125.58M	$125.58M
Net income	$-55.18M	$-126.09M	$-232.62M	$-91.92M	$-6.65M
EPS	—	—	—	—	$-1.24
Free cash flow	$-18.92M	$63.86M	$-208.28M	$-138.27M	$-52.85M
Profit margin	-33.53%	-74.90%	-210.53%	-73.20%	-73.20%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
XNCR	$861.36M	28	2.7	2.0	6.7	5.0	+70.44%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Xencor Inc trades at $11.93. Our Smart Value Score of 28/100 indicates the stock is weak. TTM revenue stands at $125.58M. with profit margins at -73.20%. Our DCF model estimates intrinsic value at $41.34.

Frequently asked questions

What is Xencor Inc's stock price?

Xencor Inc (XNCR) trades at $11.93.

Is Xencor Inc overvalued?

Smart Value Score 28/100 (Grade F, Strong Sell). DCF value $41.34.

What is the price target of Xencor Inc (XNCR)?

The analyst target price is $28.42, representing +138.2% upside from the current price of $11.93.

What is the intrinsic value of Xencor Inc (XNCR)?

Based on our DCF model, intrinsic value is $41.34, a +70.4% margin of safety versus $11.93.

What is Xencor Inc's revenue?

TTM revenue is $125.58M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio6.86x

ROE-14.10%

Beta0.99

50D MA$12.18

200D MA$12.21

Shares out0.07B

Float0.05B

Short ratio—

Avg volume0.9M

Performance

1 week-5.45%

1 month+7.05%

3 months-1.62%

YTD-20.64%

1 year—

3 years—

5 years—

Compare

XNCR vs LLY →XNCR vs JNJ →XNCR vs ABBV →Stock screener →